Background: Low-and middle-income countries (LMICs) face many challenges regarding the timely management of STEMI, and the COVID-19 pandemic has impacted our already fragile health systems.
Objectives: To assess the delays in managing STEMI during COVID-19 and evaluate the 6-month mortality rates related to these delays.
Methods: A retrospective cross-sectional study was conducted over two years at a tertiary center in Dakar, Senegal.